Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly  Settings
GHDX [NASD]
Genomic Health Inc.
Healthcare | Medical Laboratories & Research | USA
financial highlights | statements
Index- P/E167.75 EPS (ttm)0.20 Insider Own1.50% Shs Outstand30.10M Perf Week-4.93%
Market Cap1.01B Forward P/E111.83 EPS next Y0.30 Insider Trans8.08% Shs Float28.39M Perf Month-9.84%
Income6.60M PEG5.09 EPS next Q-0.08 Inst Own92.20% Short Float10.71% Perf Quarter20.29%
Sales239.80M P/S4.21 EPS this Y0.00% Inst Trans0.68% Short Ratio12.81 Perf Half Y21.08%
Book/sh4.34 P/B7.73 EPS next Y700.00% ROA4.10% Target Price35.04 Perf Year0.81%
Cash/sh3.19 P/C10.51 EPS next 5Y32.95% ROE4.90% 52W Range25.25 - 38.99 Perf YTD23.16%
Dividend- P/FCF81.44 EPS past 5Y17.70% ROI6.40% 52W High-13.95% Beta0.50
Dividend %- Quick Ratio5.40 Sales past 5Y29.70% Gross Margin84.40% 52W Low32.87% ATR1.20
Employees612 Current Ratio5.40 Sales Q/Q7.90% Oper. Margin2.80% RSI (14)41.94 Volatility4.67% 3.24%
OptionableYes Debt/Eq0.00 EPS Q/Q-250.00% Profit Margin2.80% Rel Volume0.70 Prev Close34.05
ShortableYes LT Debt/Eq0.00 EarningsMay 02 AMC Payout0.00% Avg Volume237.27K Price33.55
Recom2.40 SMA20-6.88% SMA500.19% SMA2008.63% Volume167,200 Change-1.47%
21-Feb-12Downgrade GARP Research Buy → Neutral
08-Feb-12Downgrade MLV & Co Buy → Hold $31.50 → $30
12-Dec-11Reiterated Ladenburg Thalmann Buy $26 → $32
02-Nov-11Upgrade Ladenburg Thalmann Neutral → Buy $26
11-Oct-11Reiterated RBC Capital Mkts Sector Perform $27 → $21
05-Oct-11Initiated Oppenheimer Perform $20
09-Feb-11Downgrade Ladenburg Thalmann Buy → Neutral
16-Nov-10Initiated Canaccord Genuity Hold $19
21-Apr-10Initiated RBC Capital Mkts Sector Perform
14-Apr-10Initiated William Blair Mkt Perform
22-Jan-10Upgrade Piper Jaffray Neutral → Overweight
21-Jan-10Initiated Jefferies & Co Hold $18
08-Jan-10Initiated ThinkEquity Buy
11-Jun-09Upgrade Thomas Weisel Market Weight → Overweight $23
08-Oct-08Initiated Oppenheimer Perform
08-Sep-08Downgrade Canaccord Adams Buy → Hold $24 → $22
06-Aug-08Reiterated JMP Securities Mkt Outperform $32 → $35
07-May-08Reiterated RBC Capital Mkts Outperform $27 → $26
07-May-08Reiterated Canaccord Adams Buy $22 → $24
12-Mar-08Downgrade JP Morgan Overweight → Neutral
18-Jun-13 04:47PM  5 High Growth Healthcare Stocks With Heavy Insider Buying at TheStreet
09:25AM  Stock Downgrades: Charles River Laboratories Up a Creek at Minyanville
10-Jun-13 09:16AM  GENOMIC HEALTH INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
08-Jun-13 03:00PM  Rest in Peace, Medicare? at Motley Fool
07-Jun-13 11:04AM  Synta Pharmaceuticals Director Buys 756K Shares and 3 Insider Buys to Note at Wall St. Cheat Sheet
05-Jun-13 10:52AM  Genomic Health Director Buys More Than 128K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet
04-Jun-13 10:04AM  Genomic Health Director Buys More Than 51K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet
31-May-13 10:46AM  Genomic Health Director Buys 47K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet
08:02AM  InPlay: Genomic Health provides results of ten studies in breast, prostate and colon cancers at ASCO Briefing.com
08:00AM  Genomic Health Announces Results of Ten Studies in Breast, Prostate and Colon Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire
30-May-13 10:16AM  Genomic Health Director Buys More Than 74K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet
28-May-13 04:00PM  Genomic Health to Present at Two Upcoming Investor Conferences PR Newswire
12:33PM  Insiders at Altria and Genomic Health Buy Shares While Google Sees a Sale at Minyanville
22-May-13 10:00AM  6 Ways You Can Profit From Molecular Diagnostics at Seeking Alpha
21-May-13 08:00AM  Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire
17-May-13 11:34AM  Genomic Health Director Buys More Than 52K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet
11:17AM  In Insider Trading, Harbinger Buys Spectrum Brands Stock for 11th Time Since April 9 Minyanville
16-May-13 10:10AM  Hecla Mining CEO Buys 150K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet
07:51AM  The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals Zacks
15-May-13 06:27PM  Genomic Health's New Prostate Test May Extend The Stock's Upward Climb at Seeking Alpha
05:59PM  New cancer tools allow patients to reconsider chemo at Reuters
02:30PM  Much Awaited Test Launch by Genomic Zacks
12:45PM  5 Stocks Insiders Love Right Now at TheStreet
10:23AM  An Insider Sells Major Stake of General Growth Properties While Directors at Genomic Health and US Steel Buy Stock Minyanville
09:01AM  U.S. Steel Director Buys More Than 72K Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet
14-May-13 05:45PM  3 Disruptive Technologies That Could Slash Health-Care Costs at Motley Fool
12:00PM  Myriad Genetics climbs after Jolie reveals genetic testing at theflyonthewall.com
13-May-13 01:50PM  Genomic Gains Coverage for DCIS Zacks
10:02AM  GENOMIC HEALTH INC Files SEC form 8-K, Other Events EDGAR Online
11-May-13 01:04PM  GENOMIC HEALTH INC Financials EDGAR Online Financials
10-May-13 04:04PM  InPlay: Genomic Health announces Medicare expanded coverage policy for Oncotype DX breast cancer test to include ductal carcinoma in situ (DCIS) diagnosis Briefing.com
04:02PM  Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test to Include Ductal Carcinoma in Situ (DCIS) Diagnosis PR Newswire
03:56PM  Genomic Health Inc Stock Sees Short Interest Jump 12% at Forbes
02:32PM  Tech That Disrupts Our Lives for the Better TheStreet
09-May-13 10:02AM  Companies Fighting Against Prostate Cancer at Seeking Alpha
01:10AM  Genomic Health's CEO Reviews Positive Clinical Validation and Development of the Oncotype DX Prostate Cancer Test (Transcript) at Seeking Alpha
01:10AM  Genomic Health Inc. - Special Call at Seeking Alpha
08-May-13 04:10PM  Genetic Test Helps Identify Aggressive Prostate Cancer at Bloomberg +6.35%
08:49AM  Genetic Tests Help Identify Aggressive Prostate Cancer at Bloomberg
08:02AM  InPlay: Genomic Health announces availability of Oncotype DX prostate cancer test with potential to triple the number of patients who can confidently choose active surveillance and avoid side effects of invasive treatments Briefing.com
08:00AM  Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments PR Newswire
04:49AM  InPlay: Genomic Health announces availability of Oncotype DX prostate cancer test Briefing.com
12:27AM  Gene test may help guide prostate cancer treatment AP
12:02AM  Gene test may help guide prostate cancer treatment AP
12:01AM  New Test Improves Assessment of Prostate Cancer Risk, Study Says at New York Times
12:01AM  New Test Improves Assessment of Prostate Cancer Risk, Study Says at New York Times
12:01AM  Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments PR Newswire
07-May-13 04:30PM  Genomic Health to Present at Bank of America Merrill Lynch Health Care Conference PR Newswire
09:14AM  GENOMIC HEALTH INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04-May-13 05:40PM  Earnings Volatility Drives These Stocks in a New Direction at Wall St. Cheat Sheet
03-May-13 04:22PM  Why Genomic Health Shares Popped at Motley Fool +10.23%
02-May-13 11:40PM  Genomic Health Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
07:01PM  Genomic Health Earnings: Heres Why the Stock is Down Now at Wall St. Cheat Sheet
04:26PM  GHDX Crosses Above Key Moving Average Level at TheStreet
04:21PM  InPlay: Genomic Health and ECOG-ACRIN Cancer Research Group announce publication of positive DCIS validation study in the Journal of the National Cancer Institute Briefing.com
04:20PM  Genomic Health and ECOG-ACRIN Cancer Research Group Announce Publication of Positive DCIS Validation Study in the Journal of the National Cancer Institute PR Newswire
04:01PM  Genomic Health Announces First Quarter 2013 Financial Results and Business Progress PR Newswire
11:48AM  [$$] New Prostate-Cancer Tests Bring New Hopes at Barrons.com
09:09AM  GENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
07:07AM  Q1 2013 GENOMIC HEALTH INC Earnings Release - After Market Close CCBN
01-May-13 04:00PM  Genomic Health Announces Investor Webcast and Conference Call to Review Positive Clinical Validation and Development of the Oncotype DX® Prostate Cancer Test on Wednesday, May 8, 2013 PR Newswire
27-Apr-13 01:35PM  Variations on a Gene, and Tools to Find Them at New York Times
26-Apr-13 12:52PM  FDA Acting Faster in Areas of Unmet Medical Need: An Expert Analyst Discusses the Current Regulatory Environment with The Wall Street Transcript Wall Street Transcript
05:42AM  Insiders Are Buying These 9 Environmentally Conscious Stocks at Seeking Alpha
25-Apr-13 08:00AM  Genomic Health to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 2, 2013 PR Newswire
18-Apr-13 04:08PM  Mega-Hedge Fund Focusing on the Life Sciences at Motley Fool
17-Apr-13 08:01AM  InPlay: Genomic Health announces publication of second positive validation of oncotype DX colon cancer test confirming its value beyond conventional markers Briefing.com
08:00AM  Genomic Health Announces Publication of Second Positive Validation of Oncotype DX Colon Cancer Test Confirming Its Value Beyond Conventional Markers PR Newswire
05-Apr-13 03:43PM  GHDX to Show Prostate Test Result Zacks
03-Apr-13 08:00AM  Genomic Health to Address One of the Most Significant Needs in Men's Health with the Oncotype DX® Prostate Cancer Test PR Newswire
28-Mar-13 06:24AM  4 Stocks Rising on Unusual Volume at TheStreet
26-Mar-13 01:30PM  New Prostate Cancer Tests May Supplement P.S.A. Testing at New York Times
01:30PM  New Prostate Cancer Tests Could Reduce False Alarms at New York Times
21-Mar-13 01:04PM  GENOMIC HEALTH INC Financials EDGAR Online Financials
18-Mar-13 04:54PM  Plethora of Positive Data for GHDX Zacks
15-Mar-13 05:19PM  GENOMIC HEALTH INC Files SEC form 10-K, Annual Report EDGAR Online
09:04AM  InPlay: Genomic Health presents twenty two international studies demonstrating worldwide adoption and value of oncotype DX breast cancer test; results reinforce Oncotype DX as the only genomic test to guide chemotherapy decisions Briefing.com
09:02AM  The Zacks Analyst Blog Highlights: America Movil, Grupo Televisa, Telefonica, NII Holdings and Genomic Health Zacks
08:00AM  Genomic Health Presents Twenty Two International Studies Demonstrating Worldwide Adoption and Value of Oncotype DX® Breast Cancer Test PR Newswire
14-Mar-13 04:28PM  Genomic Health Reveals Positive Results Zacks
13-Mar-13 09:03AM  InPlay: Genomic Health announces positive results from large study of Oncotype DX to quantify risk of loco-regional recurrence in node-positive breast cancer patients and acceptance of oncotype DX DCIS validation study for publication Briefing.com
08:00AM  Genomic Health Announces Positive Results from Large Study of Oncotype DX® to Quantify Risk of Loco-Regional Recurrence in Node-positive Breast Cancer Patients and Acceptance of Oncotype DX DCIS Validation Study for Publication PR Newswire
03-Mar-13 09:18PM  Myriad Genetics Win on Gene Patent Ownership Is Appealed at Bloomberg
25-Feb-13 08:05AM  Genomic Health announces results from studies involving sequencing from paraffin theflyonthewall.com
08:05AM  InPlay: Genomic Health announces results from two studies demonstrating innovations in next generation sequencing from paraffin tissue, enhancing understanding of tumor biology Briefing.com
08:00AM  Genomic Health Announces Results from Two Studies Demonstrating Innovations in Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding of Tumor Biology PR Newswire
22-Feb-13 10:15AM  In Insider Trading, Genomic Health Director Buys Shares and Iron Mountain Director Sells Minyanville
10:12AM  Genomic Health Director Buys 20.8K Shares and 4 Insider Buys Not to Miss at Wall St. Cheat Sheet
21-Feb-13 05:07PM  1 Way We Can Fix Health Care at Motley Fool
15-Feb-13 10:00AM  CarMax Director Buys 10K Shares and 4 Insider Buys Not to Miss at Wall St. Cheat Sheet
14-Feb-13 11:31PM  Myriad Genetics Wins Australia Bid to Patent Human Genes at Bloomberg
05:41PM  Myriad Genetics Wins Australian Bid to Patent Human Genes at Bloomberg
13-Feb-13 12:28PM  5 Stocks With Big Insider Buying at TheStreet
11:12AM  Genomic Health Director Buys 79.9K Shares and 4 Insider Buys Not to Miss at Wall St. Cheat Sheet
12-Feb-13 09:48AM  Opko Health CEO Buys 110K Shares and 4 Insider Buys to Note at Wall St. Cheat Sheet
08-Feb-13 08:08AM  Genomic Beats Estimates Zacks
07-Feb-13 06:02AM  GENOMIC HEALTH INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
06-Feb-13 11:12PM  Genomic Health's CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
04:21PM  InPlay: Genomic Health beats by $0.03, beats on revs; guides FY13 EPS above consensus, revs in-line Briefing.com
04:12PM  GENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Stateme EDGAR Online
Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. The company provides the Oncotype DX invasive breast cancer test that is used for early stage invasive breast cancer patients to predict the likelihood of breast cancer recurrence and the likelihood of chemotherapy benefit. It also offers the Oncotype DX colon cancer test, which is used to predict the likelihood of colon cancer recurrence in patients with stage II disease, as well as for use in patients with stage III disease treated with oxaliplatin-containing adjuvant therapy. In addition, the company provides the Oncotype DX tests for patients with ductal carcinoma in situ, a pre-invasive form of breast cancer. Genomic Health, Inc. was founded in 2000 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shak StevenEVP of R&D & CMOJun 18Sale33.525,000167,605323,283Jun 19 05:32 PM
Popovits Kimberly JPresident and CEOJun 12Option Exercise2.885,00014,40020,366Jun 14 04:39 PM
Popovits Kimberly JPresident and CEOJun 12Sale35.685,000178,40017,866Jun 14 04:39 PM
Schorno Dean LCFOJun 10Option Exercise17.334,00069,32021,836Jun 12 08:28 PM
Schorno Dean LCFOJun 10Sale35.884,000143,52517,836Jun 12 08:28 PM
Cole G BradleyCOOJun 05Option Exercise1.332,5003,32515,635Jun 07 05:34 PM
BAKER FELIXDirectorJun 05Buy35.82217,7737,799,54011,241,654Jun 05 05:23 PM
Cole G BradleyCOOJun 05Sale36.472,50091,17213,135Jun 07 05:34 PM
BAKER FELIXDirectorJun 04Buy36.62163,6595,993,19311,051,768Jun 05 05:23 PM
LIVINGSTON RANDALL SDirectorJun 03Option Exercise10.731,00010,7307,149Jun 04 07:03 PM
BAKER FELIXDirectorJun 03Buy36.69128,3414,708,43310,909,066Jun 03 05:40 PM
LIVINGSTON RANDALL SDirectorJun 03Sale36.401,00036,4006,149Jun 04 07:03 PM
BAKER FELIXDirectorMay 31Buy36.7551,2421,883,25610,797,159Jun 03 05:40 PM
BAKER FELIXDirectorMay 29Buy36.8247,0001,730,61510,752,532May 29 06:06 PM
BAKER FELIXDirectorMay 28Buy36.9374,2662,742,93310,711,599May 29 06:06 PM
BAKER FELIXDirectorMay 24Buy36.9362,5172,308,90910,646,920May 24 05:04 PM
BAKER FELIXDirectorMay 23Buy36.9116,900623,79910,592,521May 24 05:04 PM
HIBBS KATHY LSVP & General CounselMay 22Option Exercise21.071,00021,0708,087May 23 05:24 PM
HIBBS KATHY LSVP & General CounselMay 22Sale37.481,00037,4807,087May 23 05:24 PM
Shak StevenEVP of R&D & CMOMay 21Sale37.195,000185,957327,380May 22 07:54 PM
BAKER FELIXDirectorMay 16Buy36.5419,306705,42610,577,816May 16 06:03 PM
LIVINGSTON RANDALL SDirectorMay 15Option Exercise1.331,3371,7747,486May 17 05:33 PM
BAKER FELIXDirectorMay 15Buy36.4152,1331,898,36110,561,048May 16 06:03 PM
LIVINGSTON RANDALL SDirectorMay 15Sale35.831,33747,9046,149May 17 05:33 PM
BAKER FELIXDirectorMay 14Buy35.5327,184965,89910,515,769May 14 06:40 PM
Popovits Kimberly JPresident and CEOMay 13Option Exercise2.885,00014,40019,463May 15 06:08 PM
HIBBS KATHY LSVP & General CounselMay 13Option Exercise21.071,25026,3388,337May 15 06:10 PM
BAKER FELIXDirectorMay 13Buy34.19213,2427,291,16610,492,159May 14 06:40 PM
HIBBS KATHY LSVP & General CounselMay 13Sale34.421,25043,0317,087May 15 06:10 PM
Popovits Kimberly JPresident and CEOMay 13Sale34.705,000173,50616,963May 15 06:08 PM
Schorno Dean LCFOMay 09Option Exercise17.184,00068,72021,092May 13 05:33 PM
Schorno Dean LCFOMay 09Sale36.024,000144,08817,092May 13 05:33 PM
Cole G BradleyCOOMay 08Option Exercise1.332,5003,32515,040May 09 03:16 PM
Cole G BradleyCOOMay 08Sale35.992,50089,96412,540May 09 03:16 PM
Popovits Kimberly JPresident and CEOApr 23Option Exercise2.882,5007,20019,463Apr 25 05:55 PM
Popovits Kimberly JPresident and CEOApr 23Sale30.002,50075,00016,963Apr 25 05:55 PM
Cole G BradleyCOOApr 03Option Exercise1.332,5003,32515,040Apr 05 05:50 PM
Cole G BradleyCOOApr 03Sale27.792,50069,48312,540Apr 05 05:50 PM
Cole G BradleyCOOMar 06Option Exercise1.332,5003,32515,040Mar 08 04:14 PM
Cole G BradleyCOOMar 06Sale28.572,50071,43512,540Mar 08 04:14 PM
BAKER FELIXDirectorFeb 21Buy27.6428,200779,35910,306,239Feb 21 06:11 PM
BAKER FELIXDirectorFeb 20Buy27.9720,885584,22010,281,731Feb 21 06:11 PM
HIBBS KATHY LSVP & General CounselFeb 20Sale28.132,71676,3997,087Feb 22 07:50 PM
MYERS WOODROW A JRDirectorFeb 14Option Exercise18.8841,250778,63544,141Feb 15 07:32 PM
BAKER FELIXDirectorFeb 14Buy28.4334,800989,40210,263,580Feb 14 05:51 PM
MYERS WOODROW A JRDirectorFeb 14Sale28.4041,2501,171,5292,891Feb 15 07:32 PM
BAKER FELIXDirectorFeb 13Buy28.5817,200491,58510,233,478Feb 14 05:51 PM
BAKER FELIXDirectorFeb 11Buy28.2379,9842,258,08410,218,600Feb 11 06:43 PM
BAKER FELIXDirectorFeb 08Buy27.9636,3761,017,10610,149,413Feb 11 06:43 PM
Cole G BradleyCOOFeb 06Option Exercise1.332,5003,32516,585Feb 07 05:02 PM
Cole G BradleyCOOFeb 06Sale28.032,50070,07614,085Feb 07 05:02 PM
LIVINGSTON RANDALL SDirectorJan 28Option Exercise1.332,0002,6538,149Jan 29 05:22 PM
LIVINGSTON RANDALL SDirectorJan 28Sale28.772,00057,5436,149Jan 29 05:22 PM
Cole G BradleyCOOJan 09Option Exercise1.332,5003,32516,585Jan 11 07:29 PM
Schorno Dean LCFOJan 09Option Exercise9.392,62524,64919,980Jan 11 07:31 PM
Cole G BradleyCOOJan 09Sale27.882,50069,69414,085Jan 11 07:29 PM
Schorno Dean LCFOJan 09Sale28.002,62573,50017,355Jan 11 07:31 PM
Shak StevenEVP of R&D & CMODec 18Sale27.745,000138,721333,768Dec 19 07:02 PM
Popovits Kimberly JPresident and CEODec 13Sale27.795,000138,955208,406Dec 14 05:26 PM
Schorno Dean LCFODec 11Option Exercise9.393,00028,17020,355Dec 12 05:37 PM
Schorno Dean LCFODec 11Sale28.003,00084,00017,355Dec 12 05:37 PM
Cole G BradleyCOODec 06Option Exercise1.332,5003,32516,585Dec 07 06:50 PM
Cole G BradleyCOODec 06Sale27.182,50067,94714,085Dec 07 06:50 PM
LIVINGSTON RANDALL SDirectorNov 26Option Exercise1.332,0002,6538,149Nov 27 05:05 PM
LIVINGSTON RANDALL SDirectorNov 26Sale27.842,00055,6836,149Nov 27 05:05 PM
BAKER FELIXDirectorNov 21Buy27.543008,26210,117,174Nov 23 01:24 PM
BAKER FELIXDirectorNov 20Buy26.83229,0006,143,36010,116,906Nov 23 01:24 PM
Shak StevenEVP of R&D & CMONov 20Sale26.945,000134,710338,768Nov 21 05:36 PM
COLELLA SAMUEL DDirectorNov 20Sale26.525,500145,8460Nov 20 07:51 PM
COLELLA SAMUEL DDirectorNov 19Sale26.9725,116677,4841,871Nov 20 07:51 PM
BAKER FELIXDirectorNov 14Buy27.32103,1672,818,1619,914,595Nov 14 09:16 PM
Popovits Kimberly JPresident and CEONov 14Sale27.245,000136,217213,406Nov 16 06:20 PM
BAKER FELIXDirectorNov 13Buy27.99103,8392,906,6519,822,003Nov 14 09:05 PM
Schorno Dean LCFONov 12Option Exercise9.392,80026,29220,155Nov 14 03:38 PM
BAKER FELIXDirectorNov 12Buy27.94200,0005,587,4809,729,086Nov 14 09:05 PM
Schorno Dean LCFONov 12Sale28.002,80078,40017,355Nov 14 03:38 PM
Schorno Dean LCFONov 09Option Exercise9.392001,87817,555Nov 14 03:38 PM
BAKER FELIXDirectorNov 09Buy27.72519,93314,414,1959,550,108Nov 14 09:05 PM
Schorno Dean LCFONov 09Sale28.002005,60017,355Nov 14 03:38 PM
Cole G BradleyCOONov 08Option Exercise1.332,5003,32516,585Nov 13 06:43 PM
Cole G BradleyCOONov 08Sale28.622,50071,54214,085Nov 13 06:43 PM
Popovits Kimberly JPresident and CEOOct 16Option Exercise23.315,000116,55024,523Oct 17 05:59 PM
Shak StevenEVP of R&D & CMOOct 16Sale35.255,000176,254343,768Oct 18 06:38 PM
Popovits Kimberly JPresident and CEOOct 16Sale35.005,000175,00019,523Oct 17 05:59 PM
Popovits Kimberly JPresident and CEOOct 15Sale31.175,000155,839218,406Oct 17 05:59 PM
Schorno Dean LCFOOct 12Option Exercise9.393,00028,17020,355Oct 16 05:44 PM
Schorno Dean LCFOOct 12Sale33.793,000101,35817,355Oct 16 05:44 PM
HIBBS KATHY LSVP & General CounselOct 11Option Exercise21.071,25026,33812,617Oct 15 05:48 PM
HIBBS KATHY LSVP & General CounselOct 11Sale33.781,25042,22411,367Oct 15 05:48 PM
Cole G BradleyCOOOct 09Option Exercise1.332,5003,32516,585Oct 11 05:51 PM
Cole G BradleyCOOOct 09Sale34.802,50086,99014,085Oct 11 05:51 PM
Shak StevenEVP of R&D & CMOSep 18Sale33.765,000168,800348,768Sep 19 05:44 PM
Popovits Kimberly JPresident and CEOSep 13Sale31.695,000158,450223,406Sep 17 07:32 PM
Cole G BradleyCOOSep 06Option Exercise1.332,5003,32516,585Sep 10 05:43 PM
Cole G BradleyCOOSep 06Sale35.012,50087,51414,085Sep 10 05:43 PM
MYERS WOODROW A JRDirectorAug 21Option Exercise9.9510,993109,38013,229Aug 22 06:31 PM
MYERS WOODROW A JRDirectorAug 21Sale35.2810,993387,8032,236Aug 22 06:31 PM
MYERS WOODROW A JRDirectorAug 20Option Exercise9.955,50754,7957,743Aug 22 06:31 PM
MYERS WOODROW A JRDirectorAug 20Sale35.065,507193,0612,236Aug 22 06:31 PM
Shak StevenEVP of R&D & CMOAug 20Sale34.995,000174,940353,768Aug 22 06:29 PM
open in yahoo | open in reuters | open in google